HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Small Business Matters

HBW Insight’s coverage of news and issues impacting small and mid-sized enterprises.

Dutch Firm TheOTCLabs Enters UK Market With Kidsner Range

Amsterdam-based TheOTCLabs breaks into the UK consumer health market with Kidsner, a playfully marketed range of wellness products aimed at children aged 4 to 12 years old. 

United Kingdom Health

Over The Counter 26 Sept 2023: Disrupting the Consumer Health Industry, With Maxwellia’s Anna Maxwell

In this episode, HBW Insight catches up with UK switch specialists Maxwellia to find out what’s next for the company that gave to the UK one of the first OTC daily contraceptive pills. Now a disruptive consumer health player in its own right, the company is looking for investors to take it to the next level and help launch two new women’s health products in the pipeline for next year, CEO Anna Maxwell reveals in this exclusive interview.

United Kingdom Health

Get To Know: Rising UK Effervescent Wellness Star Phizz

London-based start-up Phizz markets in the UK's busy wellness category effervescent products that it claims effectively hydrate while also providing essential vitamins and minerals.

United Kingdom Wellness

UK's Maxwellia Offers Mid-Price Branded Levonorgestrel Alternative

UK consumers will soon be able to purchase at an "accessible" price branded levonorgestrel-based emergency contraceptive, LoviOne, marketed by switch specialists Maxwellia. 

United Kingdom Health

Clasado Adds 14 Markets To Bimuno’s Reach With Phytonet Partnership

A partnership with Swiss functional ingredients supplier Phytonet AG brings UK prebiotic specialist Clasado 14 steps closer to global coverage for Bimuno GOS. 

International Wellness

Flarin’s Philip Lindsell: UK ITV Backing Could Provide Springboard For International Expansion

Flarin Holdings recently secured £5m ($6.2m) investment from UK television company ITV's Media for Equity fund in return for a minority stake in the company, which markets analgesic brand Flarin in the UK. The investment could be a springboard for international expansion, including in the US, Flarin's managing director Philip Lindsell tells HBW Insight in an exclusive in-depth interview.

United Kingdom United States

Bayer CH Backs Digital Therapeutics With ‘Multimillion-Dollar’ Mahana Partnership

A multimillion-dollar partnership will bring together Bayer Consumer Health's digestive health brand equity with Mahana's cutting edge digital therapeutic technology for treating irritable bowel syndrome. 

US States Health

Labatec Gets Approval To Market Futura’s Eroxon Erectile Dysfunction Gel In Saudi Arabia

Futura Medical's MED3000 erectile dysfunction gel gets OTC approval in the Kingdom of Saudi Arabia, where Switzerland's Labatec Pharma has the rights to commercialize the product under the Eroxon brand. 

Saudi Arabia Health

Get To Know: Sweden’s Pre-Drinking ‘Myrkl’ Maker De Faire Medical

In the first of a new series profiling small- and medium-sized innovative players in the European consumer healthcare market, HBW Insight speaks to Swedish “revolutionary pre-drinking pill” manufacturer De Faire Medical.

United Kingdom Wellness

Haleon Enters US OTC Erectile Dysfunction Race With Futura Deal

Haleon steps into the US OTC erectile dysfunction market with a commercialization deal for Futura's drug-free MED3000 gel, recently approved by the FDA as a de novo medical device. 

United States Health

Over The Counter 10 July 2023: Prescription Slimming Drugs And Their OTC Alternatives, With OptiBiotix’s Stephen O’Hara

In this episode, we explore recent consumer interest in prescription weight loss drugs such as Novo Nordisk's Wegovy with gut health expert Stephen O’Hara. As CEO of microbiome specialist OptiBiotix Health, O’Hara points to over-the-counter alternatives like prebiotic food supplements and medical devices, which may offer similar hunger-reducing benefits without the side effects associated with these drugs. By successfully negotiating health claim regulations, as well as investing in new markets and in new delivery formats like gummies, companies like Optibiotix are looking to take advantage of this new interest in slimming solutions, he explains.

Europe Wellness

‘A Phenomenon’ – Futura’s Eroxon ED Gel Gets Off To Flying Start In The UK

According to Futura's UK distributor, the recent launch of its Eroxon drug-free erectile dysfunction gel has been an outstanding success. Ceuta's Jon Connolly described the strategy behind the launch at a recent investor event. 

United Kingdom Health

UK’s Maxwellia Creates AI Influencer To Counter Hormonal Contraception Misinformation

Maxwellia responds with “Lovi” – an online, interactive, AI-powered avatar – to a trending movement on TikTok that encourages women to stop taking daily contraceptives like its UK Lovima progestogen-only pill. 

United Kingdom Health

With Bricks-And-Mortar Launch, Sons Wants To Be UK’s Number-One OTC Hair Loss Brand

With the help of Ceuta Healthcare, Irish men's health specialist Careforsons is launching its hair loss treatments in UK Superdrug stores. CEO William Kennedy talks to HBW Insight about the transition from the direct-to-consumer, online, subscription-based model to the bricks-and-mortar channel, and how the company intends to differentiate itself from category incumbents like Kenvue's Regaine and Dr Wolff's Alpecin. 

United Kingdom Health

ProBiotix Capitalizes On EU Monacolins Restriction With CholBiome Extension

A recent decision by the European Commission provides UK microbiome specialist ProBiotix Health with an opportunity to present its CholBiome extension as an alternative to red yeast rice as a way to “maintain normal blood cholesterol levels.”

Europe Wellness

Haleon And Sanofi Back PulPac’s Plastic-Free Bottle Prototype

Sanofi Consumer Healthcare and Haleon have joined a partnership to scale up the manufacture of PulPac's dry molded fiber, plastic-free bottle prototype.

Europe Health